Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010

International Journal of Antimicrobial Agents

Volumn 41, Issue 6, 2013, Pages 527-535

  Balode, Arta ^a   Punda Polić, Volga ^b   Dowzicky, Michael J ^c  

^a PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c PFIZER INC   (United States)

Author keywords

Antimicrobial resistance; Eastern; Europe; Surveillance; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DRUG RESEARCH; EASTERN EUROPE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; EUROPE, EASTERN; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 84877693929     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.022     Document Type: Article

References (28)

1. A. Giedraitiene, A. Vitkauskiene, R. Naginiene, and A. Pavilonis Antibiotic resistance mechanisms of clinically important bacteria Medicina (Kaunas) 47 2011 137 146
2. D. Adukauskiene, A. Vitkauskaite, E. Skrodeniene, A. Dambrauskiene, and A. Vitkauskiene Changes in antibiotic resistance level of nosocomial Pseudomonas aeruginosa isolates in the largest university hospital of Lithuania Medicina (Kaunas) 47 2011 278 283
3. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2011.
4. I. Goic-Barisic, B. Bedenic, M. Tonkic, A. Novak, S. Katic, and S. Kalenic Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia J Clin Microbiol 47 2009 3348 3349
5. G. Młynarczyk, W. Grzybowska, A. Młynarczyk, S. Tyski, D. Kawecki, and M. Łuczak Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005 Transplant Proc 39 2007 2883 2885
6. H. Goossens, M. Ferech, R.V. Stichele, M. Elseviers, and ESAC Project Group Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009.
8. G. Kahlmeter, D.F.J. Brown, R. Canton, A.P. MacGowan, J.W. Mouton, and A. Rodloff EUCAST technical note on tigecycline Clin Microbiol Infect 12 2006 1147 1149
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). Document M100-S20U. Wayne, PA: CLSI; 2010.
11. B. Bedenic, I. Goic-Barisic, A. Budimir, M. Tonkic, L.J. Mihajkevic, and A. Novak Antimicrobial susceptibility and β-lactamase production of selected Gram-negative bacilli from two Croatian hospitals: MYSTIC study results J Chemother 22 2010 147 152
12. E. Miftode, O. Dorneanu, D. Leca, A. Teodor, D. Mihalache, and O. Filip Antimicrobial resistance profile of E. coli and Klebsiella spp. from urine in the Infectious Diseases Hospital Iaşi [in Romanian] Rev Med Chir Soc Med Nat Iasi 112 2008 478 482
13. C. Schultsz, and S. Geerlings Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy Drugs 72 2012 1 16
14. D.M. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G.M. Rossolini, and G. Arlet CTX-M: changing the face of ESBLs in Europe J Antimicrob Chemother 59 2007 165 174
15. M. Kolář, M. Chromá, K. Hricová, V. Husičková, Y. Lovečková, and E. Chmelař ová Prevalence of ESBL-positive Enterobacteriaceae in large Moravian hospitals (Czech Republic) Klin Mikrobiol Infekc Lek 16 2010 152 157 [in Czech]
16. V. Seputiene, M. Linkevicius, A. Bogdaite, J. Povilonis, R. Planciuniene, and A. Giedraitiene Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania J Med Microbiol 59 2010 1263 1265
17. E. Szilágyi, M. Füzi, I. Damjanova, K. Böröcz, K. Szonyi, and A. Tóth Investigation of extended-spectrum β-lactamase-producing Klebsiella pneumoniae outbreaks in Hungary between 2005 and 2008 Acta Microbiol Immunol Hung 57 2010 43 53
18. K. Piekarska, K. Zacharczuk, J. Szych, E. Zawidzka, E. Wilk, and S. Wardak Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland Med Dosw Mikrobiol 62 2010 9 20 [in Polish]
19. E. Chudácková, T. Bergerová, K. Fajfrlík, D. Cervená, P. Urbásková, and J. Empel Carbapenem- nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 β-lactamases in a Czech hospital FEMS Microbiol Lett 309 2010 62 70
20. A. Tóth, I. Damjanova, E. Puskás, L. Jánvári, M. Farkas, and A. Dobák Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary Eur J Clin Microbiol Infect Dis 29 2010 765 769
21. C. Thornsberry, D.F. Sahm, L.J. Kelly, I.A. Critchley, M.E. Jones, and A.T. Evangelista Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000 Clin Infect Dis 34 Suppl. 1 2002 S4 S16
22. A.P. Johnson Methicillin-resistant Staphylococcus aureus: the European landscape J Antimicrob Chemother 66 Suppl. 4 2011 iv43 iv48
23. O. Szucs, K. Kristóf, K. Darvas, and A. Csomós Changes in the incidence of multiresistant pathogens and its consequences in the intensive care unit Orv Hetil 152 2011 1486 1491 [in Hungarian]
24. A. Vitkauskiene, E. Skrodeniene, A. Dambrauskiene, A. Macas, and R. Sakalauskas Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality Medicina (Kaunas) 46 2010 490 495
25. A. Vitkauskiene, E. Skrodeniene, D. Jomantiene, A. Macas, and R. Sakalauskas Changes in the dependence of Pseudomonas aeruginosa O serogroup strains and their resistance to antibiotics in a university hospital during a 5-year period Medicina (Kaunas) 47 2011 361 367
26. P.J. van Duijn, M.J. Dautzenberg, and E.A. Oostdijk Recent trends in antibiotic resistance in European ICUs Curr Opin Crit Care 17 2011 658 665
27. M.J. Dowzicky, and E. Chmelařová Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009 Int J Antimicrob Agents 37 2011 562 566
28. X. Bertrand, and M.J. Dowzicky Antimicrobial susceptibility among Gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial Clin Ther 34 2012 124 137